361 related articles for article (PubMed ID: 18536747)
1. Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents.
Yeung S; Schwake M; Pucovský V; Greenwood Ia
Br J Pharmacol; 2008 Sep; 155(1):62-72. PubMed ID: 18536747
[TBL] [Abstract][Full Text] [Related]
2. Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity.
Yeung SY; Pucovský V; Moffatt JD; Saldanha L; Schwake M; Ohya S; Greenwood IA
Br J Pharmacol; 2007 Jul; 151(6):758-70. PubMed ID: 17519950
[TBL] [Abstract][Full Text] [Related]
3. Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm.
Mani BK; O'Dowd J; Kumar L; Brueggemann LI; Ross M; Byron KL
J Cardiovasc Pharmacol; 2013 Jan; 61(1):51-62. PubMed ID: 23107868
[TBL] [Abstract][Full Text] [Related]
4. KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways.
Brueggemann LI; Haick JM; Neuburg S; Tate S; Randhawa D; Cribbs LL; Byron KL
Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L476-86. PubMed ID: 24441871
[TBL] [Abstract][Full Text] [Related]
5. Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy.
Brueggemann LI; Kakad PP; Love RB; Solway J; Dowell ML; Cribbs LL; Byron KL
Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(1):L120-32. PubMed ID: 21964407
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological and functional effects of the KCNQ channel blocker XE991 on murine portal vein smooth muscle cells.
Yeung SY; Greenwood IA
Br J Pharmacol; 2005 Oct; 146(4):585-95. PubMed ID: 16056238
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in Kv7 channel function in the cerebral and coronary circulation.
Lee S; Yang Y; Tanner MA; Li M; Hill MA
Microcirculation; 2015 Feb; 22(2):109-121. PubMed ID: 25476662
[TBL] [Abstract][Full Text] [Related]
8. Expression and motor functional roles of voltage-dependent type 7 K(+) channels in the human taenia coli.
Adduci A; Martire M; Taglialatela M; Arena V; Rizzo G; Coco C; Currò D
Eur J Pharmacol; 2013 Dec; 721(1-3):12-20. PubMed ID: 24120659
[TBL] [Abstract][Full Text] [Related]
9. Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscle.
Afeli SA; Malysz J; Petkov GV
PLoS One; 2013; 8(9):e75875. PubMed ID: 24073284
[TBL] [Abstract][Full Text] [Related]
10. Functional assembly of Kv7.1/Kv7.5 channels with emerging properties on vascular muscle physiology.
Oliveras A; Roura-Ferrer M; Solé L; de la Cruz A; Prieto A; Etxebarria A; Manils J; Morales-Cano D; Condom E; Soler C; Cogolludo A; Valenzuela C; Villarroel A; Comes N; Felipe A
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1522-30. PubMed ID: 24855057
[TBL] [Abstract][Full Text] [Related]
11. Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine.
Schenzer A; Friedrich T; Pusch M; Saftig P; Jentsch TJ; Grötzinger J; Schwake M
J Neurosci; 2005 May; 25(20):5051-60. PubMed ID: 15901787
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of Kv7.4 channels in rat cardiac mitochondria: possible targets for cardioprotection.
Testai L; Barrese V; Soldovieri MV; Ambrosino P; Martelli A; Vinciguerra I; Miceli F; Greenwood IA; Curtis MJ; Breschi MC; Sisalli MJ; Scorziello A; Canduela MJ; Grandes P; Calderone V; Taglialatela M
Cardiovasc Res; 2016 May; 110(1):40-50. PubMed ID: 26718475
[TBL] [Abstract][Full Text] [Related]
13. Molecular and functional characterization of Kv7 K+ channel in murine gastrointestinal smooth muscles.
Jepps TA; Greenwood IA; Moffatt JD; Sanders KM; Ohya S
Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G107-15. PubMed ID: 19389803
[TBL] [Abstract][Full Text] [Related]
14. Activation of vascular KCNQ (Kv7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery.
Mani BK; Brueggemann LI; Cribbs LL; Byron KL
Br J Pharmacol; 2011 Sep; 164(2):237-49. PubMed ID: 21323904
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological dissection of K(v)7.1 channels in systemic and pulmonary arteries.
Chadha PS; Zunke F; Davis AJ; Jepps TA; Linders JT; Schwake M; Towart R; Greenwood IA
Br J Pharmacol; 2012 Jun; 166(4):1377-87. PubMed ID: 22251082
[TBL] [Abstract][Full Text] [Related]
16. The contribution of Kv7 channels to pregnant mouse and human myometrial contractility.
McCallum LA; Pierce SL; England SK; Greenwood IA; Tribe RM
J Cell Mol Med; 2011 Mar; 15(3):577-86. PubMed ID: 20132415
[TBL] [Abstract][Full Text] [Related]
17. The K
Tykocki NR; Heppner TJ; Dalsgaard T; Bonev AD; Nelson MT
J Physiol; 2019 Feb; 597(3):935-950. PubMed ID: 30536555
[TBL] [Abstract][Full Text] [Related]
18. Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release.
Vervaeke K; Gu N; Agdestein C; Hu H; Storm JF
J Physiol; 2006 Oct; 576(Pt 1):235-56. PubMed ID: 16840518
[TBL] [Abstract][Full Text] [Related]
19. Molecular variants of KCNQ channels expressed in murine portal vein myocytes: a role in delayed rectifier current.
Ohya S; Sergeant GP; Greenwood IA; Horowitz B
Circ Res; 2003 May; 92(9):1016-23. PubMed ID: 12690036
[TBL] [Abstract][Full Text] [Related]
20. Activation of KCNQ channels located on the skeletal muscle membrane by retigabine and its influence on the maximal muscle force in rat muscle strips.
Zagorchev P; Apostolova E; Kokova V; Peychev L
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):439-46. PubMed ID: 26815201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]